Table 7.

Distribution of metastasis according to site.

Visceral			Frequency	Percent		Cumulative Percent
Yes			72	67.3		67.3
No			35	32.7		100.0
Non-visceral
Yes			78	73.6		73.6
No			28	26.4		100.0
Total			104	100.0
				Visceral Metastasis				Total
				No		Yes
CDK4/6 Inhibitors	Abemaciclib		Count	4		11		15
			%	26.7%		73.3%		100.0%
	Palbociclib		Count	18		40		58
			%	31.0%		69.0%		100.0%
	Ribociclib		Count	13		21		34
			%	38.2%		61.8%		100.0%
Total			Count	35		72		107
			%	32.7%		67.3%		100.0%
Chi-Square Tests			Value	Df		Asymptotic Significance (2-sided)
Pearson Chi-Square			0.794	2		0.672
Likelihood Ratio			0.792	2		0.673
N of Valid Cases			107
					Non-visceral Metastasis		Total
					No	Yes
CDK4/6 Inhibitors		Abemaciclib		Count	6	8	14
				%	46.7%	53.3%	100.0%
		Palbociclib		Count	13	45	58
				%	22.4%	77.6%	100.0%
		Ribociclib		Count	8	26	34
				%	23.5%	76.5%	100.0%
Total				Count	28	78	106
				%	26.4%	73.6%	100.0%
Chi-Square Tests			Value	df		Asymptotic Significance (2-sided)
Pearson Chi-Square			4.630	2		0.099
Likelihood Ratio			4.167	2		0.124
N of Valid Cases			106